Supplementary Figure 3 from Pharmacokinetic and Pharmacodynamic Analysis of Circulating Biomarkers of Anti-NRP1, a Novel Antiangiogenesis Agent, in Two Phase I Trials in Patients with Advanced Solid Tumors

Authors :: Priti S. Hegde
Shuang Bai
Ryan Watts
Yibing Yan
Raymond K. Tong
Rainer Brachmann
Patricia LoRusso
Amita Patnaik
Colin D. Weekes
Rashell Kinard
Jenny Wu
Jessica Li
Yan Xin
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file, 57K, Ratio of plasma PlGF or cNRP1 to baseline for each subject at all time points evaluated (Days 14, 21) from the Phase Ia study.

Tools